Family Office Of America (FOFA) Return on Capital Employed (2022 - 2026)
Family Office Of America's (FOFA) quarterly Return on Capital Employed came in at 11.01% in Q1 2026, up 6379.0% year-on-year from 0.17% in Q1 2025, and up 86.64% quarter-over-quarter from 82.44% in Q4 2025.
Family Office Of America (FOFA) Return on Capital Employed (2022 - 2026) Analysis & Trends
Family Office Of America has disclosed Return on Capital Employed across 5 years of filings, most recently posting 11.01% for Q1 2026.
- Return on Capital Employed for Q1 2026 came in at 11.01%, up 6379.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 11.01% (up 6379.0% YoY), and the FY2025 annual result was 246.5%, down 54332.0% from the prior year.
- Return on Capital Employed came in at 11.01% for Q1 2026 at Family Office Of America, up from 82.44% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 9444.54% in Q3 2024 to a low of 1725.4% in Q3 2023.
- The 5-year median for Return on Capital Employed is 74.8% (2025), against an average of 558.74%.
- Across the five-year window, Return on Capital Employed surged 1116993 bps in 2024 and sank 948651 bps in 2025, its largest moves.
- Family Office Of America's Return on Capital Employed stood at 303.98% in 2022, then jumped by 116 bps to 49.71% in 2023, then soared by 1775 bps to 932.12% in 2024, then slumped by 109 bps to 82.44% in 2025, then jumped by 87 bps to 11.01% in 2026.
- The last three Return on Capital Employed figures came in at 11.01% (Q1 2026), 82.44% (Q4 2025), and 41.98% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 9.61% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 12.24% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 7.36% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 9.62% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 11.13% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 10.45% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 24.24% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 9.30% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 11.57% |
| 10 | Family Office Of America | - | - | 783,126.00 | -11.01% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.01% |
| Dec 31, 2025 | -82.44% |
| Sep 30, 2025 | -41.98% |
| Jun 30, 2025 | -46.42% |
| Mar 31, 2025 | -74.80% |
| Dec 31, 2024 | 932.12% |
| Sep 30, 2024 | 9,444.54% |
| Jun 30, 2024 | 3,339.63% |
| Mar 31, 2024 | -990.78% |
| Dec 31, 2023 | 49.71% |
| Sep 30, 2023 | -1,725.40% |
| Jun 30, 2023 | -1,409.50% |
| Mar 31, 2023 | -416.55% |
| Dec 31, 2022 | -303.98% |
| Sep 30, 2022 | -282.11% |